Ken Griffin Prestige Consumer Healthcare Inc. Call Options Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$58.76 - $75.07 $58,760 - $75,070
-1,000 Reduced 40.0%
1,500 $108,000
Q4 2023

Feb 14, 2024
SELL
$57.0 - $61.94 $96,900 - $105,298
-1,700 Reduced 40.48%
2,500 $153,000
Q3 2023

Nov 14, 2023
SELL
$56.7 - $68.29 $107,730 - $129,751
-1,900 Reduced 31.15%
4,200 $240,000
Q2 2023

Aug 14, 2023
BUY
$56.28 - $63.76 $292,656 - $331,552
5,200 Added 577.78%
6,100 $362,000
Q1 2023

May 15, 2023
BUY
$58.41 - $67.05 $52,569 - $60,345
900 New
900 $56,000

Others Institutions Holding PBH

# of Institutions
323
Shares Held
49.9M
Call Options Held
5.3K
Put Options Held
100
View Full List

About Prestige Consumer Healthcare Inc.

PBH Quotes by TradingView
  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.43B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email